CNMC Goldmine Holdings Limited (SGX:5TP)

Elevation Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	9.85	4.1	0.12	1.72	-3.54
Depreciation & Amortization	8.09	4.82	5.07	4.86	7.98
Loss (Gain) From Sale of Assets	-0.1	-0.17	-	-0.06	-0
Asset Writedown & Restructuring Costs	-	-	0.47	-	0.01
Other Operating Activities	3.6	0.6	1.36	0.9	-2.55
Change in Accounts Receivable	-0.44	0.08	0.2	1.96	-1.82
Change in Inventory	-2.29	5.53	-10.31	-0.6	-0.1
Change in Accounts Payable	4.49	-1.24	-2.97	-0.18	-1.23
Operating Cash Flow	23.19	13.71	-6.06	8.59	-1.25
Operating Cash Flow Growth	69.18%	-	-	-	-
Capital Expenditures	-8.57	-2.47	-5.32	-2.97	-0.86
Sale of Property, Plant & Equipment	0.1	0.09	-	0.06	0
Other Investing Activities	0.4	0.15	0.1	0.24	-
Investing Cash Flow	-8.07	-2.23	-5.21	-2.67	-0.86
Long-Term Debt Repaid	-0.5	-0.21	-0.15	-0.17	-0.18
Total Debt Repaid	-0.5	-0.21	-0.15	-0.17	-0.18
Net Debt Issued (Repaid)	-0.5	-0.21	-0.15	-0.17	-0.18
Repurchase of Common Stock	-	-	-	-0.36	-
Common Dividends Paid	-1.81	-1.21	-0.59	-	-0.58
Other Financing Activities	-1.17	-0.67	-1.21	-0.1	-0.59
Financing Cash Flow	-4.98	-2.09	-3.73	-0.62	-2.5
Foreign Exchange Rate Adjustments	-0.36	0.09	-0.15	-0.12	-0.16
Net Cash Flow	9.78	9.49	-15.15	5.18	-4.76
Free Cash Flow	14.62	11.24	-11.38	5.62	-2.1
Free Cash Flow Growth	30.05%	-	-	-	-
Free Cash Flow Margin	22.43%	21.55%	-44.45%	17.07%	-8.81%
Free Cash Flow Per Share	0.04	0.03	-0.03	0.01	-0.01
Cash Interest Paid	0.06	0.03	0.04	0.1	0.09
Cash Income Tax Paid	4.02	2.09	1.61	0.99	1.26
Levered Free Cash Flow	13.6	14.22	-10.72	8.41	-0.77
Unlevered Free Cash Flow	13.72	14.32	-10.65	8.52	-0.66
Change in Net Working Capital	-3.4	-7.17	11.96	-4.51	4.63

Updated Feb 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.